awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35678358-F457E31A-5097-41B4-A5A6-52C035EE627B
Q35678358-F457E31A-5097-41B4-A5A6-52C035EE627B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35678358-F457E31A-5097-41B4-A5A6-52C035EE627B
Sunitinib re-challenge in advanced renal-cell carcinoma.
P2860
Q35678358-F457E31A-5097-41B4-A5A6-52C035EE627B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35678358-F457E31A-5097-41B4-A5A6-52C035EE627B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
81afbc40ffe5476abff750fd2932bea84cc8a6fc
P2860
A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: final overall survival results and safety update.